Wealth Enhancement Advisory Services
CLBT icon

Wealth Enhancement Advisory Services’s Cellebrite CLBT Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.37M Sell
120,406
-286,726
-70% -$3.82M ﹤0.01% 1947
2026
Q2 		$6.49M Buy
407,132
+15,957
+4% +$211K 0.01% 863
2026
Q1 		$5.48M Buy
391,175
+2,396
+0.6% +$36.1K 0.01% 865
2025
Q4 		$7.15M Buy
388,779
+29,015
+8% +$521K 0.01% 845
2025
Q3 		$6.65M Buy
359,764
+103,568
+40% +$1.63M 0.01% 823
2025
Q2 		$3.96M Buy
256,196
+242,347
+1,750% +$4.32M 0.01% 1008
2025
Q1 		$269K Buy
+13,849
New +$291K ﹤0.01% 2531

Other funds holding CLBT

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Wealth Enhancement Advisory Services's CLBT Position: Q3 2026 in Review

Wealth Enhancement Advisory Services reduced its Cellebrite (CLBT) stake by 70% in Q3 2026, selling an estimated $3.82M and leaving 120,406 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1947.

Wealth Enhancement Advisory Services first reported a position in CLBT in Q1 2025 and has held it in 7 quarters since. The position peaked at $7.15M in Q4 2025. 5 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

  • Wealth Enhancement Advisory Services held 120,406 shares of Cellebrite worth $1.37M as of Q3 2026.
  • Wealth Enhancement Advisory Services sold 286,726 Cellebrite shares in Q3 2026, an estimated $3.82M.
  • Cellebrite made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #1947 holding.
  • Wealth Enhancement Advisory Services first reported a position in Cellebrite in Q1 2025 and has held it in 7 quarters since.
  • Wealth Enhancement Advisory Services's Cellebrite position peaked at $7.15M in Q4 2025.
  • 5 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.